Reply: Low bone mineral density is a common feature of Zellweger spectrum disorders

by Rush, Eric T., Goodwin, Jennifer L., Braverman, Nancy E., Rizzo, William B.
Published 2016

In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precur...

by Wood, Paul L, Khan, M Amin, Smith, Tara, Ehrmantraut, Greg, Jin, Wei, Cui, Wei, Braverman, Nancy E, Goodenowe, Dayan B
Published 2011

Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens

by Dorninger, Fabian, Brodde, Alexander, Braverman, Nancy E., Moser, Ann B., Just, Wilhelm W., Forss-Petter, Sonja, Brügger, Britta, Berger, Johannes
Published 2015

A founder mutation in the PEX6 gene is responsible for increased incidence of Zellweger syndrome in a French Canadian population

by Levesque, Sebastien, Morin, Charles, Guay, Simon-Pierre, Villeneuve, Josee, Marquis, Pascale, Yik, Wing Yan, Jiralerspong, Sarn, Bouchard, Luigi, Steinberg, Steven, Hacia, Joseph G, Dewar, Ken, Braverman, Nancy E
Published 2012

Phenylbutyrate increases pyruvate dehydrogenase complex activity in cells harboring a variety of defects

by Ferriero, Rosa, Boutron, Audrey, Brivet, Michele, Kerr, Douglas, Morava, Eva, Rodenburg, Richard J, Bonafé, Luisa, Baumgartner, Matthias R, Anikster, Yair, Braverman, Nancy E, Brunetti-Pierri, Nicola
Published 2014